EZZ Life Science Holdings Limited (ASX:EZZ)

Market Cap	86.32M
Revenue (ttm)	66.87M +0.6%
Net Income	6.73M -3.4%
EPS	0.15 -10.0%
Shares Out	47.04M
PE Ratio	12.61
Forward PE	n/a
Dividend	0.04 (2.18%)
Ex-Dividend Date	Nov 24, 2025

Volume	16,907
Average Volume	54,318
Open	1.840
Previous Close	1.835
Day's Range	1.765 - 1.845
52-Week Range	1.290 - 3.380
Beta	0.47
RSI	50.61
Earnings Date	Feb 25, 2026

About EZZ Life Science Holdings

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its products online. Th...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EZZ

Financial Performance

In 2025, EZZ Life Science Holdings's revenue was 66.87 million, an increase of 0.65% compared to the previous year's 66.44 million. Earnings were 6.73 million, a decrease of -3.36%.